Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Clinical trial NCT00130845 · COMPLETED

Trial details

NCT number: NCT00130845
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2000-02-01
Primary completion: 2005-12-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.